Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: A randomized placebo-controlled trial

Alcohol and Alcoholism

Volumn 47, Issue 2, 2012, Pages 149-155

  Förg, Anna ^a   Hein, Jakob ^a   Volkmar, Katharina ^a   Winter, Martin ^a   Richter, Christoph ^a,b   Heinz, Andreas ^a   Müller, Christian A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Vivantes Wenckebach Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; PLACEBO; PREGABALIN;

ADULT; AGED; ALCOHOL WITHDRAWAL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANTICONVULSANTS; DIAZEPAM; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHANOL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84857661999     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr153     Document Type: Article

References (58)

1. Amato L, Minozzi S, Davoli M. (2011) Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. The Cochrane Library 6: 1-26. Wiley online library.
2. André V, Rigoulot M-A, Koning E et al. (2003) Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 44:893-903.
3. APA (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Association.
4. Arroyo S, Anhut H, Kugler AR et al. (2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45:20-7.
5. Baidya D, Agarwal A, Khanna P et al. (2011) Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol 27:307-14.
6. Beck A, Schlagenhauf F, Wüstenberg T et al. (2009) Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 66:734-42.
7. Becker HC, Myrick H, Veatch LM. (2006) Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal. Alcohol Alcohol 41:399-406.
8. Ben-Menachem E. (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(Suppl. 6):13-18.
9. Brodie MJ. (2004) Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45:19-27.
10. Chalabianloo F, Schjøtt J. (2009) Pregabalin and its potential for abuse (article in Norwegian). Tidsskr Nor Laegeforen 129:186-7.
11. Charlson ME, Pompei P, Ales KL et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-83.
12. Chen G, Cuzon Carlson VC, Wang J et al. (2011) Striatal involvement in human alcoholism and alcohol consumption, and withdrawal in animal models. Alcohol Clin Exp Res 35:1739-48.
13. Chesler EJ, Ritchie J, Kokayeff A et al. (2003) Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain 106:325-35.
14. Cunningham MO, Woodhall GL, Thompson SE et al. (2004) Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 20:1566-76.
15. de Millas W, Ganzer F, Kuhn S et al. (2010) Oxazepam versus clomethiazol in alcohol withdrawal treatment. Eur Addict Res 16:179-84.
16. De Witte P, Pinto E, Ansseau M et al. (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189-97.
17. Dilling H, Mombour W, Schmidt MH, Schulte-Warkwort E (eds), (1994). Internationale Klassifikation psychischer Störungen ICD-10 Kapitel V (F) Forschungskriterien. WHO, Bern: Huber.
18. Di Nicola M, Martinotti G, Tedeschi D et al. (2010) Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol 25:268-75.
19. +-evoked [3H]-norepinephrine release from rat neocortical slices. Synapse 45:171-90.
20. Endicott J, Spitzer RL, Fleiss JL et al. (1976) The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-71.
21. European-Medicines-Agency. (2002) ICH Topic E 6 (R1) Guideline for Good Clinical Practice. European-Medicines-Agency: London.
22. Feltner DE, Crockatt JG, Dubovsky SJ et al. (2003) A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23:240-9.
23. Field MJ, Oles RJ, Singh L. (2001) Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity. Br J Pharmacol 132:1-4.
24. Filipetto FA, Zipp CP, Coren JS. (2010) Potential for pregabalin abuse or diversion after past drug-seeking behavior. J Am Osteopath Assoc 110:605-7.
25. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42:229-36.
26. French JA, Kugler AR, Robbins JL et al. (2003) Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60:1631-7.
27. Grosshans M, Mutschler J, Hermann D et al. (2010) Pregabalin abuse, dependence, and withdrawal: a case report. Am J Psychiatry 167:869.
28. Guy W. (1976) Clinical Global Impressions [CGI]. Rockville, MD: National Institute of Mental Health.
29. Hall W, Zador D. (1997) The alcohol withdrawal syndrome. Lancet 349:1897-900.
30. Hamilton M. (1976a) HAMA-Hamilton Anxiety Scale. In: Guy W (ed). ECDEU Assessment, Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 193-8.
31. Hamilton M. (1976b) HAMD-Hamilton Depression Scale. In: Guy W (ed). ECDEU Assessment, Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 193-8.
32. Heinz A, Mann K, Weinberger DR et al. (2001) Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res 25:487-95.
33. Leggio L, Kenna GA, Swift RM. (2008) New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog Neuropsychopharmacol Biol Psychiatry 32:1106-17.
34. Lydiard RB, Rickels K, Herman B et al. (2010) Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder. Int J Neuropsychopharmacol 13:229-41.
35. Lyon JE, Khan RA, Gessert CE et al. (2011) Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebocontrolled trial. J Hosp Med 6:474-9.
36. Malcolm R, Myrick H, Brady KT et al. (2001) Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 10:(Suppl.)16-23.
37. Martinotti G, Di Nicola M, Frustaci A et al. (2010a) Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multicentre, randomized, single-blind comparison trial. Addiction 105:288-99.
38. Martinotti G, Di Nicola M, Tedeschi D et al. (2010b) Pregabalin versus naltrexone in alcohol dependence: a randomised, doubleblind, comparison trial. J Psychopharmacol 24:1367-74.
39. Minozzi S, Amato L, Vecchi S et al. (2010) Anticonvulsants for alcohol withdrawal. The Cochrane Library 3: 1-33. Wiley online library.
40. Mottola CA. (1993) Measurement strategies: the visual analogue scale. Decubitus 6:56-8.
41. Müller CA, Schäfer M, Schneider S et al. (2010) Efficacy and safety of levetiracetam for outpatient alcohol detoxification. Pharmacopsychiatry 43:184-9.
42. Mutschler J, Grosshans M, Herwig U et al. (2011) Pregabalin-induced suicidal ideations. Pharmacopsychiatry 44:119.
43. Nevo I, Hamon M. (1995) Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26:305-36.
44. Ntais C, Pakos E, Kyzas P et al. (2005) Benzodiazepines for alcohol withdrawal (review). The Cochrane Library 3: 1-108. Wiley online library.
45. Pande AC, Crockatt JG, Feltner DE et al. (2003) Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160:533-40. Kirkland, Quebec: Pfizer Canada Inc.
46. Pfizer Canada Inc. (2010) Product Monograph Lyrica-Pregabalin Capsules (Last revision March 21, 2010).
47. Richter C, Hinzpeter A, Schmidt F et al. (2010) Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. J Clin Psychopharmacol 30:720-5.
48. Rubio G, Bobes J, Cervera G et al. (2011) Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use. Eur Addict Res 17:262-70.
49. Sheehan DV, Lecrubier Y, Sheehan H et al. (1998) The mini-international neuropsychiatric interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22-57.
50. Skinner HA, Allen BA. (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209.
51. 2δ ligands: voltage sensitive calcium channel (VSCC) modulators. J Clin Psychiatry 65:1033-4.
52. Stein DJ, Baldwin DS, Baldinetti F et al. (2008) Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol 18:422-30.
53. Sullivan JT, Sykora K, Schneiderman J et al. (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353-7.
54. Tsai G, Coyle JT. (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173-84.
55. Tsai G, Gastfriend DR, Coyle JT. (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332-40.
56. Wetterling T, Kanitz R-D, Besters B et al. (1997) A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS Scale). Alcohol Alcohol 32:753-60.
57. Williams D, McBride AJ. (1998) The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol Alcohol 33:103-15.
58. WMA. http://infomed.mds-ev.de/sindbad.nsf/971fe478dd839c3bc12571e700442bec/c8d230ed7bee042200256983005b2c27/FILE/DoH_TOKYO_2004.pdf (24 October 2011, date last accessed).